Liposomal Irinotecan Combination Regimen for First-line Treatment of Small Cell Lung Cancer
Clinical trial NCT06462105 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06462105
- Sponsor
- Zhou Chengzhi
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-05
- Primary completion
- 2027-06-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.